Home  >  News
Veterinary + Font Resize -

Zydus Cadila to get Phibro's poultry vaccine technologies from Phibro Animal Health

Our Bureau, Mumbai
Thursday, July 6, 2017, 16:50 Hrs  [IST]

Zydus Cadila and Phibro Animal Health Corporation, Israel, have decided to enter into a  long-term arrangement to license Phibro’s innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Zydus Cadila to serve the fast growing poultry market in India. Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, dairy, beef cattle and aquaculture.

Jack Bendheim, chairman, president and chief executive offcier of Phibro, remarked, “We are proud of the more than 20-year partnership with Zydus Cadila serving the Indian animal health market and we view this as an exciting next step in our relationship.”

Speaking on the development Pankaj R. Patel, chairman and managing director, Zydus group said, “Our endeavour has always been to enable access to innovative therapies across geographies and this agreement with Phibro will help bring innovations to the poultry market in India. The availability of new advanced poultry vaccines, which were until now being imported into India, adds a new dimension to the Make-in-India movement in the animal health segment.”

With a strong presence in the livestock and poultry segments, Zydus Animal Health  is India’s leading animal healthcare player and a market leader in various therapeutic segments which include antibacterials, NSAIDs, antimastitis, tonics and poultry vaccines  amongst others in India. Zydus Animal Health has introduced the highest number of ‘First in India’ products, in keeping with its mission to provide innovative solutions that improve animal health and farm productivity.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |